Science | Technology | Therapy

At GAIA we are focused on the development of evidence-based, safe and accessible digital therapeutics that help patients restore and maintain their mental and physical health.

  • Over 20 years of experience
  • More than 70 products
  • Clinically proven effectiveness in more than 19 RCTs and 2 meta-analyses


Mario Weiss on GAIA’s Strategie

Digital Therapeutics (DTx)

Our mission is to develop digital therapeutics that offer physicians, therapists, payers and patients the same effect sizes, similar safety profiles and equal levels of convenience as found in well-developed, pharmaceutical solutions.

With a team of multidisciplinary experts, we cover all competencies required to develop, launch and maintain top-of-class products for major markets. Our team includes experienced physicians and psychotherapists, clinical scientists experienced in orchestrating Phase II & III trials, IT and software engineers, regulatory affairs experts as well as market access specialists.

Learn more about our digital therapeutics

Clinically proven effectiveness

We believe that RCT-evidence is key. This is why our digital therapeutics are extensively tested in unbiased, ethical and professionally designed randomized controlled trials (RCTs).

One of our most researched products is deprexis®, the online program for the treatment of depression. deprexis® has been shown to effectively reduce symptoms of depression in 13 randomized controlled trials (RCTs) as well as in real-life, clinical settings with effect sizes similar to those of antidepressants.

Learn more about our research and studies


Thank you for your message!

We will get in touch with you soon.